Report Scope & Overview:
AI Diagnostics Market size was valued at USD 946.90 Million in 2022 and is projected to reach USD 9,944.40 Million by 2030, growing at a CAGR of 33.7% from 2023 to 2030.
AI Diagnostics Market Overview:
Global AI Diagnostics Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. AI Diagnostics Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, AI Diagnostics market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, AI Diagnostics market research is expected to experience further growth and innovation in the coming years.
Global AI Diagnostics Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. AI Diagnostics Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, AI Diagnostics market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, AI Diagnostics market research is expected to experience further growth and innovation in the coming years.
DESCIMG1
AI Diagnostics Market Key Trends
Early Disease Detection: AI was increasingly used for early disease detection and diagnosis. Machine learning algorithms could analyze medical images, such as X-rays, MRIs, and CT scans, to identify abnormalities or disease markers at an early stage.
Cancer Diagnosis and Treatment: AI was playing a crucial role in cancer diagnosis, including the detection of breast cancer, lung cancer, and skin cancer. AI algorithms could assist radiologists and pathologists in identifying cancerous lesions and determining treatment plans.
Radiology AI: AI-driven radiology tools were becoming more prevalent, offering automated interpretation of medical images and aiding in the identification of various conditions, from fractures to neurological disorders.
Pathology and Histopathology: AI was being used in digital pathology and histopathology for the analysis of tissue samples. Automated image analysis could assist pathologists in diagnosing diseases and assessing tissue characteristics.
Cardiac Imaging: AI algorithms were used to analyze cardiac imaging data, such as echocardiograms and cardiac MRIs, to detect heart conditions, assess cardiac function, and identify cardiovascular risk factors.
Point-of-Care Diagnostics: AI-powered point-of-care diagnostic devices were being developed for rapid and accurate testing of diseases, including infectious diseases. These devices offered quick results and reduced the need for centralized laboratory testing.
Market Segmentations:Global AI Diagnostics Market: By Company
• Oxitone Medical Ltd
• MC10, Inc
• Medtronic
• UE LifeSciences
• Vital Connect
• Biomeme
• MidMark Corp
• Bio SB
• Cerora
• CellScope
• Digital Diagnostics
• Siemens Healthineers
• Nanox
• Roche
Global AI Diagnostics Market: By Type
• Hardware
• Software
• Service
Global AI Diagnostics Market: By Application
• Hospitals
• Research Laboratories
• Contract Research Organizations
• Others
Global AI Diagnostics Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global AI Diagnostics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 946.90 Million |
| Market Size 2030 | USD 9,944.40 Million |
| Compound Annual Growth Rate (CAGR) | 33.7%(2023-2030) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Hardware • Software • Service |
| By Application | • Hospitals • Research Laboratories • Contract Research Organizations |
| Key Companies Profiled | • Oxitone Medical Ltd • MC10, Inc • Medtronic • UE LifeSciences • Vital Connect • Biomeme • MidMark Corp • Bio SB • Cerora • CellScope • Digital Diagnostics • Siemens Healthineers • Nanox • Roche |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase AI Diagnostics Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.
Objectives of AI Diagnostics Market Study:
The objectives of AI Diagnostics market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of AI Diagnostics market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of AI Diagnostics market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.
Frequently Asked Questions
AI Diagnostics Market size was valued at USD 946.90 Million in 2022 and is projected to reach USD 9,944.40 Million by 2030, growing at a CAGR of 33.7% from 2023 to 2030.
The primary drivers include the need for accurate and efficient diagnostic solutions, the increasing prevalence of chronic diseases, and advances in AI and machine learning technologies.
Challenges include data interoperability, privacy concerns, and ensuring the seamless integration of AI algorithms into existing healthcare workflows.
Collaboration between AI companies and healthcare stakeholders fosters innovation, research, and the development of AI-driven diagnostic solutions.
The market outlook depends on factors like technological advancements, regulatory developments, and increasing demand for accurate diagnostics.
TABLE OF CONTENT
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Diagnostics Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global AI Diagnostics Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Diagnostics Market Perspective (2017-2032)
2.2 AI Diagnostics Growth Trends by Region
2.2.1 Global AI Diagnostics Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 AI Diagnostics Historic Market Size by Region (2017-2023)
2.2.3 AI Diagnostics Forecasted Market Size by Region (2023-2032)
2.3 AI Diagnostics Market Dynamics
2.3.1 AI Diagnostics Industry Trends
2.3.2 AI Diagnostics Market Drivers
2.3.3 AI Diagnostics Market Challenges
2.3.4 AI Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Diagnostics Players by Revenue
3.1.1 Global Top AI Diagnostics Players by Revenue (2017-2023)
3.1.2 Global AI Diagnostics Revenue Market Share by Players (2017-2023)
3.2 Global AI Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Diagnostics Revenue
3.4 Global AI Diagnostics Market Concentration Ratio
3.4.1 Global AI Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Diagnostics Revenue in 2022
3.5 AI Diagnostics Key Players Head office and Area Served
3.6 Key Players AI Diagnostics Product Solution and Service
3.7 Date of Enter into AI Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Diagnostics Breakdown Data by Type
4.1 Global AI Diagnostics Historic Market Size by Type (2017-2023)
4.2 Global AI Diagnostics Forecasted Market Size by Type (2023-2032)
5 AI Diagnostics Breakdown Data by Application
5.1 Global AI Diagnostics Historic Market Size by Application (2017-2023)
5.2 Global AI Diagnostics Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America AI Diagnostics Market Size (2017-2032)
6.2 North America AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America AI Diagnostics Market Size by Country (2017-2023)
6.4 North America AI Diagnostics Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Diagnostics Market Size (2017-2032)
7.2 Europe AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe AI Diagnostics Market Size by Country (2017-2023)
7.4 Europe AI Diagnostics Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Diagnostics Market Size (2017-2032)
8.2 Asia-Pacific AI Diagnostics Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific AI Diagnostics Market Size by Region (2017-2023)
8.4 Asia-Pacific AI Diagnostics Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Diagnostics Market Size (2017-2032)
9.2 Latin America AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America AI Diagnostics Market Size by Country (2017-2023)
9.4 Latin America AI Diagnostics Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Diagnostics Market Size (2017-2032)
10.2 Middle East & Africa AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa AI Diagnostics Market Size by Country (2017-2023)
10.4 Middle East & Africa AI Diagnostics Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oxitone Medical Ltd
11.1.1 Oxitone Medical Ltd Company Detail
11.1.2 Oxitone Medical Ltd Business Overview
11.1.3 Oxitone Medical Ltd AI Diagnostics Introduction
11.1.4 Oxitone Medical Ltd Revenue in AI Diagnostics Business (2017-2023)
11.1.5 Oxitone Medical Ltd Recent Development
11.2 MC10, Inc
11.2.1 MC10, Inc Company Detail
11.2.2 MC10, Inc Business Overview
11.2.3 MC10, Inc AI Diagnostics Introduction
11.2.4 MC10, Inc Revenue in AI Diagnostics Business (2017-2023)
11.2.5 MC10, Inc Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic AI Diagnostics Introduction
11.3.4 Medtronic Revenue in AI Diagnostics Business (2017-2023)
11.3.5 Medtronic Recent Development
11.4 UE LifeSciences
11.4.1 UE LifeSciences Company Detail
11.4.2 UE LifeSciences Business Overview
11.4.3 UE LifeSciences AI Diagnostics Introduction
11.4.4 UE LifeSciences Revenue in AI Diagnostics Business (2017-2023)
11.4.5 UE LifeSciences Recent Development
11.5 Vital Connect
11.5.1 Vital Connect Company Detail
11.5.2 Vital Connect Business Overview
11.5.3 Vital Connect AI Diagnostics Introduction
11.5.4 Vital Connect Revenue in AI Diagnostics Business (2017-2023)
11.5.5 Vital Connect Recent Development
11.6 Biomeme
11.6.1 Biomeme Company Detail
11.6.2 Biomeme Business Overview
11.6.3 Biomeme AI Diagnostics Introduction
11.6.4 Biomeme Revenue in AI Diagnostics Business (2017-2023)
11.6.5 Biomeme Recent Development
11.7 MidMark Corp
11.7.1 MidMark Corp Company Detail
11.7.2 MidMark Corp Business Overview
11.7.3 MidMark Corp AI Diagnostics Introduction
11.7.4 MidMark Corp Revenue in AI Diagnostics Business (2017-2023)
11.7.5 MidMark Corp Recent Development
11.8 Bio SB
11.8.1 Bio SB Company Detail
11.8.2 Bio SB Business Overview
11.8.3 Bio SB AI Diagnostics Introduction
11.8.4 Bio SB Revenue in AI Diagnostics Business (2017-2023)
11.8.5 Bio SB Recent Development
11.9 Cerora
11.9.1 Cerora Company Detail
11.9.2 Cerora Business Overview
11.9.3 Cerora AI Diagnostics Introduction
11.9.4 Cerora Revenue in AI Diagnostics Business (2017-2023)
11.9.5 Cerora Recent Development
11.10 CellScope
11.10.1 CellScope Company Detail
11.10.2 CellScope Business Overview
11.10.3 CellScope AI Diagnostics Introduction
11.10.4 CellScope Revenue in AI Diagnostics Business (2017-2023)
11.10.5 CellScope Recent Development
11.11 Digital Diagnostics
11.11.1 Digital Diagnostics Company Detail
11.11.2 Digital Diagnostics Business Overview
11.11.3 Digital Diagnostics AI Diagnostics Introduction
11.11.4 Digital Diagnostics Revenue in AI Diagnostics Business (2017-2023)
11.11.5 Digital Diagnostics Recent Development
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Detail
11.12.2 Siemens Healthineers Business Overview
11.12.3 Siemens Healthineers AI Diagnostics Introduction
11.12.4 Siemens Healthineers Revenue in AI Diagnostics Business (2017-2023)
11.12.5 Siemens Healthineers Recent Development
11.13 Nanox
11.13.1 Nanox Company Detail
11.13.2 Nanox Business Overview
11.13.3 Nanox AI Diagnostics Introduction
11.13.4 Nanox Revenue in AI Diagnostics Business (2017-2023)
11.13.5 Nanox Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche AI Diagnostics Introduction
11.14.4 Roche Revenue in AI Diagnostics Business (2017-2023)
11.14.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Diagnostics Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global AI Diagnostics Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Diagnostics Market Perspective (2017-2032)
2.2 AI Diagnostics Growth Trends by Region
2.2.1 Global AI Diagnostics Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 AI Diagnostics Historic Market Size by Region (2017-2023)
2.2.3 AI Diagnostics Forecasted Market Size by Region (2023-2032)
2.3 AI Diagnostics Market Dynamics
2.3.1 AI Diagnostics Industry Trends
2.3.2 AI Diagnostics Market Drivers
2.3.3 AI Diagnostics Market Challenges
2.3.4 AI Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Diagnostics Players by Revenue
3.1.1 Global Top AI Diagnostics Players by Revenue (2017-2023)
3.1.2 Global AI Diagnostics Revenue Market Share by Players (2017-2023)
3.2 Global AI Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Diagnostics Revenue
3.4 Global AI Diagnostics Market Concentration Ratio
3.4.1 Global AI Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Diagnostics Revenue in 2022
3.5 AI Diagnostics Key Players Head office and Area Served
3.6 Key Players AI Diagnostics Product Solution and Service
3.7 Date of Enter into AI Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Diagnostics Breakdown Data by Type
4.1 Global AI Diagnostics Historic Market Size by Type (2017-2023)
4.2 Global AI Diagnostics Forecasted Market Size by Type (2023-2032)
5 AI Diagnostics Breakdown Data by Application
5.1 Global AI Diagnostics Historic Market Size by Application (2017-2023)
5.2 Global AI Diagnostics Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America AI Diagnostics Market Size (2017-2032)
6.2 North America AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America AI Diagnostics Market Size by Country (2017-2023)
6.4 North America AI Diagnostics Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Diagnostics Market Size (2017-2032)
7.2 Europe AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe AI Diagnostics Market Size by Country (2017-2023)
7.4 Europe AI Diagnostics Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Diagnostics Market Size (2017-2032)
8.2 Asia-Pacific AI Diagnostics Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific AI Diagnostics Market Size by Region (2017-2023)
8.4 Asia-Pacific AI Diagnostics Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Diagnostics Market Size (2017-2032)
9.2 Latin America AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America AI Diagnostics Market Size by Country (2017-2023)
9.4 Latin America AI Diagnostics Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Diagnostics Market Size (2017-2032)
10.2 Middle East & Africa AI Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa AI Diagnostics Market Size by Country (2017-2023)
10.4 Middle East & Africa AI Diagnostics Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oxitone Medical Ltd
11.1.1 Oxitone Medical Ltd Company Detail
11.1.2 Oxitone Medical Ltd Business Overview
11.1.3 Oxitone Medical Ltd AI Diagnostics Introduction
11.1.4 Oxitone Medical Ltd Revenue in AI Diagnostics Business (2017-2023)
11.1.5 Oxitone Medical Ltd Recent Development
11.2 MC10, Inc
11.2.1 MC10, Inc Company Detail
11.2.2 MC10, Inc Business Overview
11.2.3 MC10, Inc AI Diagnostics Introduction
11.2.4 MC10, Inc Revenue in AI Diagnostics Business (2017-2023)
11.2.5 MC10, Inc Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic AI Diagnostics Introduction
11.3.4 Medtronic Revenue in AI Diagnostics Business (2017-2023)
11.3.5 Medtronic Recent Development
11.4 UE LifeSciences
11.4.1 UE LifeSciences Company Detail
11.4.2 UE LifeSciences Business Overview
11.4.3 UE LifeSciences AI Diagnostics Introduction
11.4.4 UE LifeSciences Revenue in AI Diagnostics Business (2017-2023)
11.4.5 UE LifeSciences Recent Development
11.5 Vital Connect
11.5.1 Vital Connect Company Detail
11.5.2 Vital Connect Business Overview
11.5.3 Vital Connect AI Diagnostics Introduction
11.5.4 Vital Connect Revenue in AI Diagnostics Business (2017-2023)
11.5.5 Vital Connect Recent Development
11.6 Biomeme
11.6.1 Biomeme Company Detail
11.6.2 Biomeme Business Overview
11.6.3 Biomeme AI Diagnostics Introduction
11.6.4 Biomeme Revenue in AI Diagnostics Business (2017-2023)
11.6.5 Biomeme Recent Development
11.7 MidMark Corp
11.7.1 MidMark Corp Company Detail
11.7.2 MidMark Corp Business Overview
11.7.3 MidMark Corp AI Diagnostics Introduction
11.7.4 MidMark Corp Revenue in AI Diagnostics Business (2017-2023)
11.7.5 MidMark Corp Recent Development
11.8 Bio SB
11.8.1 Bio SB Company Detail
11.8.2 Bio SB Business Overview
11.8.3 Bio SB AI Diagnostics Introduction
11.8.4 Bio SB Revenue in AI Diagnostics Business (2017-2023)
11.8.5 Bio SB Recent Development
11.9 Cerora
11.9.1 Cerora Company Detail
11.9.2 Cerora Business Overview
11.9.3 Cerora AI Diagnostics Introduction
11.9.4 Cerora Revenue in AI Diagnostics Business (2017-2023)
11.9.5 Cerora Recent Development
11.10 CellScope
11.10.1 CellScope Company Detail
11.10.2 CellScope Business Overview
11.10.3 CellScope AI Diagnostics Introduction
11.10.4 CellScope Revenue in AI Diagnostics Business (2017-2023)
11.10.5 CellScope Recent Development
11.11 Digital Diagnostics
11.11.1 Digital Diagnostics Company Detail
11.11.2 Digital Diagnostics Business Overview
11.11.3 Digital Diagnostics AI Diagnostics Introduction
11.11.4 Digital Diagnostics Revenue in AI Diagnostics Business (2017-2023)
11.11.5 Digital Diagnostics Recent Development
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Detail
11.12.2 Siemens Healthineers Business Overview
11.12.3 Siemens Healthineers AI Diagnostics Introduction
11.12.4 Siemens Healthineers Revenue in AI Diagnostics Business (2017-2023)
11.12.5 Siemens Healthineers Recent Development
11.13 Nanox
11.13.1 Nanox Company Detail
11.13.2 Nanox Business Overview
11.13.3 Nanox AI Diagnostics Introduction
11.13.4 Nanox Revenue in AI Diagnostics Business (2017-2023)
11.13.5 Nanox Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche AI Diagnostics Introduction
11.14.4 Roche Revenue in AI Diagnostics Business (2017-2023)
11.14.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche
Delivery Microcatheter Market
Global Delivery Microcatheter Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Elastography System Market
Global Elastography System Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Orthopedic Robots Market
Global Orthopedic Robots Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Allergy Non-pharmacologic Therapy Market
Global Allergy Non-pharmacologic Therapy Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast
Dental Anaesthetic Needles Market
Global Dental Anaesthetic Needles Market Size, Share, Trends, Growth, Industry Analysis, Key Players, Revenue, Future Development & Forecast